VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,598 | -96.6% | 1,409 | -95.0% | 0.00% | -100.0% |
| Q2 2023 | $460,202 | -19.3% | 28,390 | -17.2% | 0.00% | 0.0% |
| Q1 2023 | $570,580 | +57.4% | 34,269 | -11.2% | 0.00% | 0.0% |
| Q4 2022 | $362,558 | +1150.2% | 38,570 | +727.3% | 0.00% | – |
| Q3 2021 | $29,000 | -3.3% | 4,662 | -5.9% | 0.00% | – |
| Q2 2021 | $30,000 | -6.2% | 4,953 | -1.0% | 0.00% | – |
| Q1 2021 | $32,000 | +300.0% | 5,002 | +242.8% | 0.00% | – |
| Q4 2020 | $8,000 | -65.2% | 1,459 | -62.8% | 0.00% | – |
| Q3 2020 | $23,000 | -23.3% | 3,925 | -5.1% | 0.00% | – |
| Q2 2020 | $30,000 | +50.0% | 4,135 | -2.5% | 0.00% | – |
| Q1 2020 | $20,000 | -37.5% | 4,243 | +5.2% | 0.00% | – |
| Q4 2019 | $32,000 | +18.5% | 4,033 | +1.2% | 0.00% | – |
| Q3 2019 | $27,000 | -20.6% | 3,987 | -2.6% | 0.00% | – |
| Q2 2019 | $34,000 | -17.1% | 4,095 | -1.3% | 0.00% | – |
| Q1 2019 | $41,000 | – | 4,151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |